Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Debt / NOTE 3.000%10/1
-
Unit price / market price
-
$0.5423
-
Total 13F principal
-
$146,918,494
-
Principal change
-
-$23,416,160
-
Total reported value
-
$90,613,439
-
Number of holders
-
11
-
Value change
-
-$11,662,000,470
-
Number of buys
-
2
-
Number of sells
-
4
Institutional Holders of KARYOPHARM THERAPEUTICS INC - NOTE 3.000%10/1 as of Q1 2024
As of 31 Mar 2024 KARYOPHARM THERAPEUTICS INC - NOTE 3.000%10/1 had 11 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $146,918,494 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included BRAIDWELL LP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Davidson Kempner Capital Management LP, CAPSTONE INVESTMENT ADVISORS, LLC, Birch Grove Capital LP, LAZARD ASSET MANAGEMENT LLC, DeepCurrents Investment Group LLC, Verition Fund Management LLC, BLB&B Advisors, LLC, and JPMORGAN CHASE & CO.
This table shows 11 bond principal holders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.